Scientific Session

Update and Safety Issues on Recently Approved Agents for Rheumatic Disease

Speaker(s)

• SK

  Sabiha Khan, MD

  FDA
  Vienna, VA, United States

  Disclosure: Disclosure(s): No financial relationships with ineligible companies to disclose